Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Faster shoulder rehab after surgery: does starting day one help?

NCT ID NCT03804853

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether starting an accelerated shoulder rehabilitation program immediately after reverse total shoulder replacement leads to better pain relief and function than the standard rehab approach. About 74 people with shoulder osteoarthritis will be randomly assigned to one of the two rehab programs. Researchers will track their progress for a year using questionnaires and range-of-motion tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
physical therapy (immediate accelerated shoulder rehabilitation vs. standard protocol)
What this could lead to
If the accelerated rehab works better, patients could recover shoulder function and comfort faster after reverse shoulder replacement surgery.
What could go wrong
This is a small, early-stage trial (74 people) comparing two rehab approaches. The accelerated protocol might not prove better than standard care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 74 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2018

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \> 55 years of age. * Candidate for a primary reverse total shoulder arthroplasty. * Capable of completing self-administered questionnaires. * Be willing and able to return for all study-related follow-up procedures. * Able and willing to give informed consent. * Proficient in the English language. Exclusion Criteria: In-Clinic: * Patients planning on undergoing a Primary Reverse Shoulder Total Arthroplasty due to proximal humeral fracture. * Previous shoulder surgery including previous total shoulder arthroplasty or reverse total shoulder arthroplasty or hemiarthroplasty, or instability repairs * Active bacterial infection of the shoulder. * Any concomitant shoulder procedure. * Additional ipsilateral or contralateral upper limb pathology that requires active treatment (i.e. surgery or brace). * Inflammatory arthropathy. * Diagnosed with Rheumatoid arthritis * Diagnosed with gout. * Subject is on chronic anticoagulation due to a bleeding disorder or has taken anticoagulants within 10 days prior to surgery. * Peripheral vascular disease or other vascular disorders that would impair healing. * Peripheral neuropathy or other neurological disorders that may impair the patient to ambulate. * Patient is on workers compensation. * Any condition requiring chemotherapy. * Active tobacco user or former tobacco user who is not free of using tobacco for 8 weeks. * Uncontrolled Diabetes Mellitus with an HbA1C \> 7.5%. * Current drug or alcohol abuse. * Major medical illness (life expectancy less then 2 years or unacceptably high operative risk) * Suspicion of cervical radiculopathy or myelopathy. * Deltoid insufficiency on physical examination. Intra-operative: • Iatrogenic glenoid fracture Post-operative: * Neurological injury of the upper extremity. * Complications from Primary Reverse Shoulder Total Arthroplasty (i.e. post-operative infection, bleeding, hardware failure).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Massive irreparable rotator cuff tear are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • TRIA Orthopaedic Center

    RECRUITING

    Bloomington, Minnesota, 55431, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.